Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Introducing New and Underused Vaccines

Promoting the Value of New and Underused Vaccines

The lives of more than 2 million children under 5 years old could be saved if Haemophilus influenzae type b (Hib), pneumococcal, and rotavirus vaccines were used in all countries. Using these vaccines can result in at least a 40% reduction in the deaths caused each year by pneumonia and diarrhea among children younger than 5 years old. CDC provides scientific evidence to countries throughout the world for the introduction of many new and underused vaccines, including those against: cholera, Hib, hepatitis B, human papillomavirus (HPV), Japanese Encephalitis, serogroup A meningococcus, pneumococcus, rotavirus, rubella, typhoid, and yellow fever.

A mom with her child standing in line to receive the vaccine to protect against deadly yellow fever in Sierra Leone.

Vaccines work. This mother in Sierra Leone will be protected from yellow fever.

Introducing Vaccines to Country Immunization Programs

CDC actively participates in the evaluation, introduction, and research of available and underused vaccines. These vaccines have the potential to reduce global illness and death caused by vaccine-preventable diseases.

  • Page last reviewed: January 27, 2014
  • Page last updated: January 27, 2014
  • Content source: Global Health
  • Notice: Linking to a non-federal site does not constitute an endorsement by HHS, CDC or any of its employees of the sponsors or the information and products presented on the site. The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO